High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AI120898
National Institutes of Health
Grant: AI122390
National Institutes of Health
Grant: DA046100
National Institutes of Health
Grant: R01AI158617
National Institutes of Health
Grant: U19AI082630
National Institutes of Health
Grant: UM1AI148574
NIAID NIH HHS
Grant: R21 AI122390
NIAID NIH HHS
Grant: R33 AI122390
NIDA NIH HHS
Grant: DP1 DA046100
NIAID NIH HHS
Grant: K08 AI120898
NIAID NIH HHS
Grant: T32 AI074492
National Institutes of Health
Grant: 5R33AI122390-04
Dendritic Cell Vaccine for Controlling the Latent Reservoir
National Institutes of Health
Grant: 2U19AI082630-06
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
National Institutes of Health
Grant: 5R01AI158617-02
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
National Institutes of Health
Grant: 5UM1AI148574-06
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
National Institutes of Health
Grant: 1DP1DA046100-01
Therapeutic Dendritic Cell Vaccine for HIV
National Institutes of Health
Grant: 5K08AI120898-03
Lentiviral Vector Vaccine for HIV-1
Merck
Eli Lilly and Company
Pfizer
FWCI
1.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals